XRTX Stock Analysis: Buy, Sell, or Hold?
XRTX - XORTX Therapeutics Inc. Common Stock
$2.79
0.14 (5.28%)
▲
5d:
+0.36%
30d:
+22.1%
90d:
+596.8%
BUY
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 21, 2026
12d
Get Alerted When XRTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: XRTX shows positive signals but monitor for confirmation. Market pricing in 22.9% growth. Moderate conviction.
💡 BUY OPPORTUNITY: XRTX shows positive signals but monitor for confirmation. Market pricing in 22.9% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.16
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.34
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: XRTX is currently trading at $2.79, which is considered slightly high relative to its 30-day fair value range of $1.50 to $3.09. From a valuation perspective, the stock is trading at a premium (Forward PE: 2.5) compared to its historical average (1.4). At these levels, the market is pricing in 22.9% annual earnings growth.
Technical Outlook: Technically, XRTX is in a strong uptrend. Immediate support is located at $2.60, while resistance sits at $3.07. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.04 (+403.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XRTX is in a strong uptrend. Immediate support is located at $2.60, while resistance sits at $3.07. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.04 (+403.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.50 -
$3.09
Company Quality Score
52/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
68.6%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Strong upward momentum (+5.3%)
- BULLISH: Trading 403.1% below Wall St target ($14.04)
- BULLISH: Expecting earnings turnaround to 22.9% growth with None% revenue growth
Trading Range Analysis
30-Day Trading Range
$1.50 -
$3.09
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.60
Resistance Level
$3.07
Current Trend
Strong Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.53
Wall Street Target
$14.04
(+403.1%)
Earnings Growth (YoY)
-97.2%
Valuation Premium vs History
+22.9% premium
PE vs Historical
2.5 vs 1.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+22.9%
(market-implied from PE analysis)
1-Year Target
$3.43
(+23%)
2-Year Target
$4.21
(+51%)
3-Year Target
$5.18
(+86%)
3-Yr Target (if PE normalizes)
(PE: 3→1)
PE COMPRESSION
$2.86
(+3%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: May 08, 2026 6:58 PM ET
Data refreshes hourly during market hours. Next update: 7:58 PM
Data refreshes hourly during market hours. Next update: 7:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XRTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 54 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$298 | 60 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 54 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 63 BUY |
